tirzepatide trial

tirzepatide trial once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide trial shows additional 21.1%

Name: tirzepatide trial once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide trial shows additional 21.1%
Brand: actil.am
SKU: 60050537913
Price: 21.08 USD
Availability: InStock
Rating: 4.1683 (21 reviews)

SKU: 60050537913

4.2

USD21.08 USD50.08

Pay in 4 interest-free payments of $5.27 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 28 - Sep 2

Description

Understanding these interactions is crucial for optimizing therapy and ensuring that patients achieve their desired outcomes without unintended effects on their hormonal balance

Tchang 1

For context on how GLP-1 medications work and why they have become so popular for weight management, the core mechanism involves mimicking hormones that regulate appetite, blood sugar, and gastric emptying